D. E. Shaw & Co., Inc. United Therapeutics Corp Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 42,021 shares of UTHR stock, worth $14.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

42,021

Previous 42,232 0.5%

Holding current value

$14.9 Million

Previous $9.7 Million 37.98%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$228.26 - $319.04 $48,162 - $67,317	-211 Reduced 0.5%	42,021 $13.4 Million
Q1 2024 May 15, 2024	SELL	$210.76 - $249.51 $10 Million - $11.8 Million	-47,467 Reduced 52.92%	42,232 $9.7 Million
Q4 2023 Feb 14, 2024	BUY	$214.88 - $256.94 $991,241 - $1.19 Million	4,613 Added 5.42%	89,699 $19.7 Million
Q3 2023 Nov 14, 2023	SELL	$211.82 - $248.24 $791,359 - $927,424	-3,736 Reduced 4.21%	85,086 $19.2 Million
Q2 2023 Aug 14, 2023	SELL	$205.19 - $232.99 $16.2 Million - $18.4 Million	-78,905 Reduced 47.04%	88,822 $19.6 Million
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $940,350 - $1.22 Million	4,415 Added 2.7%	167,727 $37.6 Million
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $26.1 Million - $35.5 Million	126,512 Added 343.78%	163,312 $45.4 Million
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $10.3 Million - $12.4 Million	-50,832 Reduced 58.01%	36,800 $7.71 Million
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $2.04 Million - $2.82 Million	-11,684 Reduced 11.76%	87,632 $20.7 Million
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $13.4 Million - $17.2 Million	-80,391 Reduced 44.73%	99,316 $17.8 Million
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $19.9 Million - $23.3 Million	-107,720 Reduced 37.48%	179,707 $38.8 Million
Q3 2021 Nov 15, 2021	SELL	$179.86 - $214.88 $18.4 Million - $21.9 Million	-102,121 Reduced 26.22%	287,427 $53.1 Million
Q2 2021 Aug 16, 2021	BUY	$170.47 - $211.93 $2.74 Million - $3.41 Million	16,086 Added 4.31%	389,548 $69.9 Million
Q1 2021 May 17, 2021	SELL	$153.94 - $174.85 $17.1 Million - $19.4 Million	-110,854 Reduced 22.89%	373,462 $62.5 Million
Q4 2020 Feb 16, 2021	SELL	$101.87 - $151.79 $17.9 Million - $26.6 Million	-175,340 Reduced 26.58%	484,316 $73.5 Million
Q3 2020 Nov 16, 2020	BUY	$99.9 - $121.13 $15.9 Million - $19.3 Million	159,354 Added 31.85%	659,656 $66.6 Million
Q2 2020 Aug 14, 2020	SELL	$92.74 - $125.82 $8.66 Million - $11.8 Million	-93,396 Reduced 15.73%	500,302 $60.5 Million
Q1 2020 May 15, 2020	SELL	$79.39 - $115.35 $29 Million - $42.2 Million	-365,473 Reduced 38.1%	593,698 $56.3 Million
Q4 2019 Feb 14, 2020	BUY	$78.31 - $95.34 $3.53 Million - $4.3 Million	45,115 Added 4.94%	959,171 $84.5 Million
Q3 2019 Nov 14, 2019	BUY	$74.85 - $85.99 $6.04 Million - $6.94 Million	80,708 Added 9.68%	914,056 $72.9 Million
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $42.5 Million - $67.4 Million	558,275 Added 202.96%	833,348 $65.1 Million
Q1 2019 May 15, 2019	SELL	$107.15 - $126.84 $17.4 Million - $20.5 Million	-162,003 Reduced 37.07%	275,073 $32.3 Million
Q4 2018 Feb 14, 2019	BUY	$101.4 - $128.73 $3.42 Million - $4.35 Million	33,763 Added 8.37%	437,076 $47.6 Million
Q3 2018 Nov 14, 2018	BUY	$113.81 - $129.46 $4.94 Million - $5.62 Million	43,393 Added 12.06%	403,313 $51.6 Million
Q2 2018 Aug 14, 2018	SELL	$101.14 - $118.31 $5.29 Million - $6.18 Million	-52,272 Reduced 12.68%	359,920 $40.7 Million
Q1 2018 May 15, 2018	SELL	$107.21 - $151.94 $20.3 Million - $28.7 Million	-188,948 Reduced 31.43%	412,192 $46.3 Million
Q4 2017 Feb 14, 2018	BUY	$118.58 - $151.28 $5.46 Million - $6.97 Million	46,063 Added 8.3%	601,140 $88.9 Million
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $63.6 Million - $75.9 Million	555,077	555,077 $65 Million

Others Institutions Holding UTHR

# of Institutions

618

Shares Held

45M

Call Options Held

368K

Put Options Held

410K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account